2m 2m 2m 2m 2m 2m 2m
Lyra Therapeutcs (LYRA)
OTC
$0.35-$0.13 (-26.74%)
Price as of Mar 16, 2026 7:59 PM EDT- $781,125.00Market Cap
- -93.19%1-Year Change
- BiotechnologyIndustry
Lyra Therapeutcs (LYRA)
$0.35-$0.13 (-26.74%)
LYRA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.47 | ||
Change | -$0.02 (-5.00%) | ||
Open | $0.47 | ||
High | $0.47 | ||
Low | $0.47 | ||
Previous Close | $0.50 | ||
Volume | 204 | ||
30-Day Average Volume | 18,260 | ||
1-Week Change | -8.65% | ||
1-Month Change | -20.30% | ||
1-Year Change | -93.19% | ||
3-Year Change | -99.71% | ||
5-Year Change | -99.85% | ||
Fundamentals | |||
Shares Outstanding | 1.8M | ||
Total Assets | $43.7M | ||
Market Cap | $781,125.00 | ||
Enterprise Value | -$21.3M | ||
Period: QTR TTM FY | |||
Revenue | $25,000.00 | ||
Net Income | -$6.0M | ||
Free Cash Flow | -$7.4M | ||
EBIT | -$6.0M | ||
EBITDA | -$5.9M | ||
Net Working Capital | $13.5M | ||
EPS | -$3.38 | ||
Enterprise Value/EBITDA | 4 | ||
Enterprise Value/Revenue | -851 | ||
P/B | -0 | ||
P/E | -0 | ||
PEG | -0 | ||
Price/Free Cash Flow | -0 | ||
Price/Operating Cash Flow | -0 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 50 | ||
Last Split Date | 05/28/2025 | ||